loader
Please Wait
Applying Filters...

EuroAPI Header EuroAPI Header

X

Annual Sales of Irbesartan Hydrochlorothiazide reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 Aprovel/Avapro (1)

02 Irbetan Franchise (1)

URL Supplier Web Content
Aprovel
Cardiovascular Diseases
EURO
674
652
735
711
24
3
URL Supplier Web Content
Aprovel
Cardiovascular Diseases
EURO
674
652
735
711
24
3
URL Supplier Web Content
Irbetan Franchise
Cardiovascular Diseases
YEN
4
7
40
66
-26
-39
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Aprovel
Cardiovascular Diseases
EURO
554
674
670
815
-145
-18
URL Supplier Web Content
Aprovel
Cardiovascular Diseases
EURO
554
674
670
815
-145
-18
URL Supplier Web Content
Irbetan Franchise
Cardiovascular Diseases
YEN
4
4
34
41
-7
-16
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Aprovel
Cardiovascular Diseases
EURO
419
554
461
604
-143
-24
URL Supplier Web Content
Irbetan Franchise
Cardiovascular Diseases
YEN
3
4
28
33
-5
-8
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Aprovel
Cardiology/Vascular Diseases
EURO
478
419
524
461
63
14
URL Supplier Web Content
Irbetan Franchise
Cardiology/Vascular Diseases
YEN
3
3
25
28
-3
-11
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Post Enquiry
POST ENQUIRY